Skip to main content
Stephen Textor, MD, Nephrology, Rochester, MN, Park Nicollet Methodist Hospital

StephenCTextorMD

Nephrology Rochester, MN

Hypertension, Kidney & Pancreas Transplantation, Renovascular Medicine

Professor, Internal Medicine, Mayo Medical School

Dr. Textor is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Textor's full profile

Already have an account?

Summary

  • Board Certified Nephrologist practicing transplantation medicine, hypertension, renovascular disease and clinical investigation

Education & Training

  • Boston University Medical Center
    Boston University Medical CenterFellowship, Nephrology, 1977 - 1978
  • Boston University Medical Center
    Boston University Medical CenterResidency, Internal Medicine, 1973 - 1977
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 1973
  • Stanford University
    Stanford UniversityB.S., Chemistry, 1969

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 1988 - 2024
  • CA State Medical License
    CA State Medical License 1983 - 2019
  • OH State Medical License
    OH State Medical License 1979 - 1984
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

  • Marvin Moser Clinical Hypertension Awardee American Society of Hypertension, 2015
  • America's Top Doctors Castle Connolly, 2003-2014
  • “Laureate” award for clinical excellence Mayo Clinic, Department of Medicine, 2005
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Emerging Evidence on Renal Denervation for the Treatment of Hypertension  
    Christina M Wyatt, Stephen C Textor, Kidney International
  • Changes in inflammatory biomarkers after renal revascularization in atherosclerotic renal artery stenosis  
    Wang W , Saad A , Herrmann SM , Eirin Massat A , McKusick MA , Misra S , Lerman LO , Textor SC, Nephrol Dial Transplant, 1/29/2016
  • Differences in GFR and Tissue Oxygenation, and Interactions between Stenotic and Contralateral Kidneys in Unilateral Atherosclerotic Renovascular Disease  
    Herrmann SM , Saad A , Eirin A , Woollard J , Tang H , McKusick MA , Misra S , Glockner JF , Lerman LO , Textor SC, Clin J Am Soc Nephrol, 1/7/2016
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Functional Alterations of Adipose-Derived Mesenchymal Stem Cells from Human with Atherosclerotic Renovascular Disease Under Hypoxic Conditions
    Saad A, Dietz AB, Herrmann S, Eirin A, Aly AAA, Tang H, Kwon SH, Jordan KL, Woollard JR, Grande JP, Lerman LO, Textor SC, ASN Kidney Week, San Diego, CA, 1/1/2015
  • Safety of Intra-Arterial Autologous Adipose-Derived Mesenchymal Stem Cells in Human Atherosclerotic Renovascular Disease
    Saad A, Herrmann S, Mckusick MA, Misra S, Glockner J, Eirin A, Grande JP, Dietz AB, Lerman LO, Textor SC, ASN Kidney Week, San Diego, CA, 1/1/2015
  • Elevated Renal Injury Biomarkers Fall Transiently After Stenting in Human Atherosclerotic Renal Artery Stenosis (ARAS)
    Wang W, Saad A, Herrmann S, Eirin A, Tang H, Lerman LO, Textor SC, ASN Kidney Week, San Diego, CA, 1/1/2015
  • Join now to see all

Other

  • Nephrosclerosis 
    Fervenza FC, Textor SC, Rosenthal D, eMedicine from WebMD
    1/1/2008

Press Mentions

  • Renal Denervation for Resistant Hypertension Shows Benefit at 3 Years
    Renal Denervation for Resistant Hypertension Shows Benefit at 3 YearsJune 9th, 2020

Grant Support

  • Tissue Oxygenation In Human Renovascular HypertensionNational Heart, Lung, And Blood Institute2007–2011

Hospital Affiliations